Check out $KBLM - extend deadline in early July and trying to close their deal with CannBioRx (auto-immune disease, anti-inflamitory, arthritis, IBS, etc), and they're supported by some big name researchers at Stanford and Oxford.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
